US biopharmaceuticals supplier AbbVie's proposed acquisition of Dublin-based Allergan has been approved by South Korea's antitrust agency, MLex has learned.
It is understood that the Korea Fair Trade Commission, or KFTC, cleared the deal
without conditions.
The merger was reviewed through the regulator's "fast-track" review procedure, which means the agency didn't